Breaking News
A new study shows that influenza vaccination may help protect against heart attack and stroke even when it does not prevent people from getting the flu.
Researchers have found that adults 65 and older who received a high-dose influenza vaccine had a significantly lower risk of developing Alzheimer’s disease compared to those who received the standard dose.
FDA has approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe leukocyte adhesion deficiency type I.
BioTrending
- By Amy Scanlin, MS
This revolutionary technology shows promise for addressing a myriad of challenges in medicine, but ethical dilemmas remain.
- By Diane L.M. Cook
Known as liquid gold, human plasma is proving to be a valuable ally in the fight against cancer.
- By Jim Trageser
While still in their early stages of research, FDA has approved more than a dozen complement inhibitors to treat various conditions, and there is hope that more will be on the horizon to treat others.
- By Trudie Mitschang
Virtual hospitals bring hospital-level care directly to patients' homes, representing a transformative step in healthcare delivery.
Awards
BSTQ is an Industry Award-Winning Journal
Since its debut in 2009, BioSupply Trends Quarterly’s articles have been recognized by some of the industry’s most prominent organizations, earning platinum and gold awards.
BSTQ Podcast
Healthcare Marketplace News & Insights
The BioSupply Trends Quarterly (BSTQ) Podcast brings together healthcare professionals, researchers, innovators and advocates to explore the scientific, clinical and operational trends shaping the future of biotherapeutics, healthcare delivery and public health.
